Prognostic value of the SPOP mutant genomic subclass in prostate cancer

preview_player
Показать описание
Eric Klein, MD, Glickman Urology & Kidney Institute, Cleveland, OH, reviews a publication he co-authored on the prognostic value of SPOP mutant genomic subclass in prostate cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
  1. VJOncology
  2. Speaker: Eric Klein
  3. Institution: Glickman Urology & Kidney Institute
  4. Format: Interview
  5. Event: VJVirtual
  6. Subject: Prostate Cancer
Рекомендации по теме
Prognostic value of 0:02:51

Prognostic value of the SPOP mutant genomic subclass in prostate cancer

Treatment Intensification, SPOP 0:10:10

Treatment Intensification, SPOP Gene Alterations in Advanced Prostate Cancer

Genomic and clinical 0:01:46

Genomic and clinical features of SPOP mutations in prostate cancer

Keynote: Towards Understanding 0:39:08

Keynote: Towards Understanding Lineage Plasticity Cancer Resistance - Prof. MD. Mark Rubin

Levi A. Garraway, 0:33:10

Levi A. Garraway, MD, PhD - Celebration of Science

JC : Genomic 0:59:45

JC : Genomic alterations in Prostate cancer

[Kevin Litchfield] Meta-analysis 0:26:47

[Kevin Litchfield] Meta-analysis of tumor/T cell-intrinsic sensitization to checkpoint inhibition

CCMB Seminar 04/05/2023 1:02:36

CCMB Seminar 04/05/2023 Lixing Yang, PhD

CMR in valvular 0:33:17

CMR in valvular diseases -Dr. M Kolentinis (MD, PhD) (Athens CMR Level 1-2;2023)

Genomic Testing for 0:35:29

Genomic Testing for Clinical Decision Making in Patients with Advanced Prostate Cancer - M. A. Rubin

Genomic Markers and 0:12:05

Genomic Markers and DNA Sequencing Testing

Screening for Prostate 0:20:42

Screening for Prostate Cancer

Genomic Drivers of 1:00:41

Genomic Drivers of AR Reprogramming and Therapeutic Sensitivity in Prostate Cancer

Molecular genomics of 0:26:06

Molecular genomics of prostate cancer - Scott A. Tomlins

Clinical relevance of 0:40:24

Clinical relevance of genomics in definitive management of prostate cancer

AR V7 Predicts 0:21:52

AR V7 Predicts Response in CRPC

AR Resistance Mechanisms 0:12:02

AR Resistance Mechanisms Focusing on Variants and Testing

Modeling Drivers of 0:43:07

Modeling Drivers of Prostate Cancer Progression and Therapeutic Sensitivity

Oxford University surgical 0:42:01

Oxford University surgical lectures: Genomics of prostate cancer

E01.1 Genome sequencing 0:25:27

E01.1 Genome sequencing in prostate cancer

Variants to Networks 1:06:35

Variants to Networks by Robin Haw

Variants to Networks 1:04:48

Variants to Networks

AORTIC Basic Translational 1:02:24

AORTIC Basic Translational Research SIG Webinar

UROWebinar: WHO 2022 1:09:13

UROWebinar: WHO 2022 Classification of Male Genitourinary Tract tumor: What is relevant?